| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.48B | +56.2% |
| Cost of Revenue | $789.2M | +39.4% |
| Gross Profit | $3.69B | +60.3% |
| R&D Expense | $557.7M | +9.8% |
| SG&A Expense | $657.7M | +10.8% |
| Operating Income | $1.41B | +355.5% |
| Pre-tax Income | $1.66B | +238.8% |
| Income Tax | $22.7M | +6.9% |
| Net Income | $1.63B |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.42B | -32.2% |
| Short-term Investments | $5.75B | +83.7% |
| Accounts Receivable | $1.04B | +81.2% |
| Current Assets | $8.36B | +40.8% |
| Total Assets | $8.90B | +40.4% |
| Current Liabilities | $1.18B | +18.0% |
| Total Liabilities | $1.41B | +13.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.13B | +85.0% |
| Capital Expenditures | $33.9M | +168.2% |
| Investing Cash Flow | -$2.78B | -717.1% |
| Financing Cash Flow | -$26.9M | -105.8% |
| Free Cash Flow | $2.10B | +84.1% |
| +251.6% |
| EPS (Basic) | $0.69 | +228.6% |
| EPS (Diluted) | $0.63 | +231.6% |
| Stockholders' Equity |
| $7.39B |
| +47.6% |